Headline:
Flood death toll stands at 110: DGHS      Schedule of postponed SSC exams after distribution of textbooks in flood-hit areas: Dipu Moni      Ahead of Eid PM declares MPO benefits for 2716 educational institutions      PM unveils country’s first business incubator aimed at building smart Bangladesh     
Headline

Bharat Biotech

(About 17 results)

77.8% efficacy, robust antibody response: 5 points from Lancet's new study on Covaxin

  • November 12, 2021
  • 801
The Lancet peer-review has now corroborated Hyderabad-based Bharat Biotech's efficacy analysis regarding Covaxin, its coronavirus disease (Covid-19) vaccine, and confirmed that the shot demonstrates 7...

AIIMS to begin Phase 2/3 trials of Bharat Biotech’s nasal Covid-19 vaccine within couple of weeks: Reports

  • September 09, 2021
  • 736
Phase 2/3 trials of Bharat Biotech International Limited’s nasal vaccine against the coronavirus disease (Covid-19) are likely to begin “within a couple of weeks” at the All India Institute of M...

'India likely to have Covid shot for children by September'

  • August 19, 2021
  • 1046
India is likely to have its indigenous Covid-19 vaccine for children by September, Director of Indian Council of Medical Research (ICMR)'s National Institute of Virology (Pune) Priya Abraham said. ...

India’s Bharat Biotech says vaccine 93.4% effective against severe COVID-19

  • July 08, 2021
  • 905
Indian company Bharat Biotech said on Saturday its late-stage testing of a COVID-19 vaccine has shown an overall efficacy of 77.8% and effectiveness against all variants. The company in a statement s...

India may firm up plans to export Bharat Biotech’s Covaxin

  • May 24, 2021
  • 847
Dhaka, May 24 (UNB)--India has received enquiries from other countries for the export of the indigenous Covid 19 vaccine Covaxin jointly developed by Bharat Biotech and the Indian Council of Medical R...

Covid-19: Why ‘world’s pharmacy’ India is short on shots

  • May 23, 2021
  • 955
Last year, Indian Prime Minister Narendra Modi told the United Nations his country would make enough COVID-19 vaccines “to help all humanity.” Now India is struggling to meet its own domestic need...

India's Serum to produce Covid jabs overseas: Report

  • May 01, 2021
  • 1295
Unable to cope with the growing demand for its Covid-19 jabs in India and abroad, the Serum Institute is reportedly planning to soon start the production of the Oxford-AstraZeneca vaccine in other cou...

Covishield and Covaxin: What we know about India's Covid-19 vaccines

  • March 14, 2021
  • 1878

India's Covaxin, the homegrown government-backed vaccine, has an efficacy rate of 81%, preliminary data from its phase 3 trial shows.

India's regulators gave the vaccine an emerge...

Covid-19 in Bangladesh: Daily infection rate rises, 8 more die

  • March 01, 2021
  • 1193

Eight more Covid-19-related deaths and 585 new cases were reported in Bangladesh in the last 24 hours till Monday morning, showing a substantial rise in its daily infection rate.

The Dire...

India vaccine developer warns some to avoid shot

  • January 20, 2021
  • 1031

India’s homegrown vaccine developer Bharat Biotech has warned people with weaker immunity and other medical conditions that include allergies, fever, or a bleeding disorder to consult a docto...